Backstrom Jay T. bought AGIO
July 8, 2025 · Form 4 insider transaction
Backstrom Jay T. bought 4,341 shares of Agios Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
4,341
Price
$0.00
Total value
N/A
InsiderBackstrom Jay T.
RoleDirector
SecurityRestricted stock units
Transaction codeA: Grant or award
Transaction dateJuly 8, 2025
Filing dateJuly 10, 2025
Shares owned after4,341
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.; The restricted stock units were granted on July 8, 2025. Beginning on July 8, 2026, the shares underlying the restricted stock units will vest in three equal annual installments.